Roche Rolls Out Lung Cancer Drug In India

by Medindia Content Team on  April 12, 2006 at 6:17 PM Cancer News
RSS Email Print This Page Comment bookmark
Font : A-A+

Roche Rolls Out Lung Cancer Drug In India
Indian Pharmaceutical Industry is richer with the availability of one more beneficial drug, used in the treatment of lung cancer. Tarceva, the name by which the drug is known is produced by the Swiss-pharma company Roche, and will now be available in India

This is certainly a fresh lease of life to nearly 1, 60, 000 lung cancer patients in India. Tarceva has been available in the US since 2004 and in the European Union since 2005. This drug is normally administered to patients with advanced lung cancer, who have not responded well to even one chemotherapy treatment.

Tarceva is an established effective treatment for lung cancer, and perhaps the only epidermal growth factor receptor-inhibitor, to offer high survival rates in the treatment of lung cancer

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Lung Biopsy Lung Cancer Cancer and Homeopathy Signature Drug Toxicity Cancer Facts Asbestosis Cancer Pneumoconiosis Smoking among Women 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive